The Effects of Bioactive Compounds on Human Brain Structures and Diseases
Conflicts of Interest
References
- Tost, H.; Champagne, F.A.; Meyer-Lindenberg, A. Environmental influence in the brain, human welfare and mental health. Nat. Neurosci. 2015, 18, 1421–1431. [Google Scholar] [CrossRef] [PubMed]
- Feigin, V.L.; Vos, T.; Nichols, E.; Owolabi, M.O.; Carroll, W.M.; Dichgans, M.; Deuschl, G.; Parmar, P.; Brainin, M.; Murray, C. The global burden of neurological disorders: Translating evidence into policy. Lancet Neurol. 2020, 19, 255–265. [Google Scholar] [CrossRef] [PubMed]
- GBD. Global, regional, and national burden of neurological disorders, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019, 18, 459–480. [Google Scholar] [CrossRef] [PubMed]
- Abrahams, B.S.; Geschwind, D.H. Advances in autism genetics: On the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9, 341–355. [Google Scholar] [CrossRef] [PubMed]
- Halder, S.; Anand, U.; Nandy, S.; Oleksak, P.; Qusti, S.; Alshammari, E.M.; El-Saber Batiha, G.; Koshy, E.P.; Dey, A. Herbal drugs and natural bioactive products as potential therapeutics: A review on pro-cognitives and brain boosters perspectives. Saudi Pharm. J. 2021, 29, 879–907. [Google Scholar] [CrossRef] [PubMed]
- Walsh, T.; McClellan, J.M.; McCarthy, S.E.; Addington, A.M.; Pierce, S.B.; Cooper, G.M.; Nord, A.S.; Kusenda, M.; Malhotra, D.; Bhandari, A.; et al. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia. Science 2008, 320, 539–543. [Google Scholar] [CrossRef] [PubMed]
- Wu, P.-f.; Zhang, Z.; Wang, F.; Chen, J.-g. Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury. Acta Pharmacol. Sin. 2010, 31, 1523–1531. [Google Scholar] [CrossRef] [PubMed]
- Malaquias, G.; Cerqueira, G.; Ferreira, P.; Pacheco, A.; Sousa, J.; Deus, M.; Peron, A. Utilização na medicina popular, potencial terapêutico e toxicidade em nível celular das plantas Rosmarinus officinalis L., Salvia officinalis L. e Mentha piperita L. (Família Lamiaceae). RevInter Rev. Intertox Toxicol. Risco Ambient. Soc. 2014, 7, 50–68. [Google Scholar] [CrossRef]
- Puri, V.; Kanojia, N.; Sharma, A.; Huanbutta, K.; Dheer, D.; Sangnim, T. Natural product-based pharmacological studies for neurological disorders. Front. Pharmacol. 2022, 13, 1011740. [Google Scholar] [CrossRef] [PubMed]
- Ratcliffe, C.; Wandschneider, B.; Baxendale, S.; Thompson, P.; Koepp, M.J.; Caciagli, L. Cognitive Function in Genetic Generalized Epilepsies: Insights From Neuropsychology and Neuroimaging. Front. Neurol. 2020, 11, 144. [Google Scholar] [CrossRef] [PubMed]
- Kumar, G.P.; Khanum, F. Neuroprotective potential of phytochemicals. Pharmacogn. Rev. 2012, 6, 81–90. [Google Scholar] [CrossRef] [PubMed]
- Barba-Ostria, C.; Carrera-Pacheco, S.E.; Gonzalez-Pastor, R.; Heredia-Moya, J.; Mayorga-Ramos, A.; Rodríguez-Pólit, C.; Zúñiga-Miranda, J.; Arias-Almeida, B.; Guamán, L.P. Evaluation of Biological Activity of Natural Compounds: Current Trends and Methods. Molecules 2022, 27, 4490. [Google Scholar] [CrossRef] [PubMed]
- Shoaib, S.; Ansari, M.A.; Fatease, A.A.; Safhi, A.Y.; Hani, U.; Jahan, R.; Alomary, M.N.; Ansari, M.N.; Ahmed, N.; Wahab, S.; et al. Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection. Pharmaceutics 2023, 15, 749. [Google Scholar] [CrossRef] [PubMed]
- Yan, H.; Li, L.; Tang, X.C. Treating senile dementia with traditional Chinese medicine. Clin. Interv. Aging 2007, 2, 201–208. [Google Scholar] [PubMed]
- Zhang, Z.; Zhang, S.; Lui, C.N.-P.; Zhu, P.; Zhang, Z.; Lin, K.; Dai, Y.; Yung, K.K.-L. Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease. J. Neurorestoratol. 2019, 7, 207–222. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kiskova, T.; Smajda, B. The Effects of Bioactive Compounds on Human Brain Structures and Diseases. Int. J. Mol. Sci. 2024, 25, 3326. https://doi.org/10.3390/ijms25063326
Kiskova T, Smajda B. The Effects of Bioactive Compounds on Human Brain Structures and Diseases. International Journal of Molecular Sciences. 2024; 25(6):3326. https://doi.org/10.3390/ijms25063326
Chicago/Turabian StyleKiskova, Terezia, and Benadik Smajda. 2024. "The Effects of Bioactive Compounds on Human Brain Structures and Diseases" International Journal of Molecular Sciences 25, no. 6: 3326. https://doi.org/10.3390/ijms25063326